Theranostics in neuroendocrine tumours: somatostatin receptor imaging and therapy.
作者： Deborah Pencharz , Gopinath Gnanasegaran , Shaunak Navalkissoor
DOI: 10.1259/BJR.20180108
关键词: Internal medicine 、 Selection (genetic algorithm) 、 Medicine 、 Somatostatin receptor 、 Diagnostic test 、 Oncology
摘要: Theranostics and its principles: pre-treatment selection of patients who are most likely to benefit from treatment by the use a related, specific diagnostic test integral of...
birpublications.org参考文章(78)
Seong-Jang Kim, Kyoungjune Pak, Phillip J. Koo, Jennifer J. Kwak, Samuel Chang, The efficacy of 177 Lu-labelled peptide receptor radionuclide therapy in patients with neuroendocrine tumours: a meta-analysis European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 42, pp. 1964- 1970 ,(2015) , 10.1007/S00259-015-3155-X
Phillip G. Claringbold, J. Harvey Turner, NeuroEndocrine Tumor Therapy with Lutetium-177-octreotate and Everolimus (NETTLE): A Phase I Study Cancer Biotherapy and Radiopharmaceuticals. ,vol. 30, pp. 261- 269 ,(2015) , 10.1089/CBR.2015.1876
David Taïeb, Philippe Garrigue, Manuel Bardiès, Ahmad Esmaeel Abdullah, Karel Pacak, Application and Dosimetric Requirements for Gallium-68–labeled Somatostatin Analogues in Targeted Radionuclide Therapy for Gastroenteropancreatic Neuroendocrine Tumors PET Clinics. ,vol. 10, pp. 477- 486 ,(2015) , 10.1016/J.CPET.2015.06.001
Mauro Cives, Jonathan Strosberg, An update on gastroenteropancreatic neuroendocrine tumors. Oncology. ,vol. 28, pp. 749- 758 ,(2014)
Massimo Falconi, Detlef Klaus Bartsch, Barbro Eriksson, Günter Klöppel, José M. Lopes, Juan M. O'Connor, Ramón Salazar, Babs G. Taal, Marie Pierre Vullierme, Dermot O'Toole, ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms of the Digestive System: Well-Differentiated Pancreatic Non-Functioning Tumors Neuroendocrinology. ,vol. 95, pp. 120- 134 ,(2012) , 10.1159/000335587
Daniel Kaemmerer, Vikas Prasad, Wolfgang Daffner, Dieter Hörsch, Günter Klöppel, Merten Hommann, Richard P Baum, Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor World Journal of Gastroenterology. ,vol. 15, pp. 5867- 5870 ,(2009) , 10.3748/WJG.15.5867
Lisa Bodei, Mark Kidd, Giovanni Paganelli, Chiara M. Grana, Ignat Drozdov, Marta Cremonesi, Christopher Lepensky, Dik J. Kwekkeboom, Richard P. Baum, Eric P. Krenning, Irvin M. Modlin, Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 42, pp. 5- 19 ,(2015) , 10.1007/S00259-014-2893-5
A. Hubalewska-Dydejczyk, K. Fröss-Baron, R. Mikołajczak, H. R. Maecke, B. Huszno, D. Pach, A. Sowa-Staszczak, B. Janota, P. Szybiński, J. Kulig, 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 33, pp. 1123- 1133 ,(2006) , 10.1007/S00259-006-0113-7
Amir Sabet, Torjan Haslerud, Ulrich-Frank Pape, Amin Sabet, Hojjat Ahmadzadehfar, Frank Grünwald, Stefan Guhlke, Hans-Jürgen Biersack, Samer Ezziddin, Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 41, pp. 205- 210 ,(2014) , 10.1007/S00259-013-2547-Z
Phillip G. Claringbold, Paul A. Brayshaw, Richard A. Price, J. Harvey Turner, Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive disseminated neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 38, pp. 302- 311 ,(2011) , 10.1007/S00259-010-1631-X